Comparison of Morphological, Virulence, and Antifungal Susceptibility Characteristics Within Aspergillus Lentulus

Xiaodong Wang1, Cuirong Gao2, Aikedai Yusufu1

  • 1Department of Dermatology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, People's Republic of China.

PubMed
Abstract

Insights

Emerging Aspergillus lentulus shows varied growth and virulence, with clinical strains being more potent. This fungus is susceptible to posaconazole but resistant to voriconazole, amphotericin B, and caspofungin.

Area of Science:

  • Medical Mycology
  • Infectious Diseases

Background:

  • Aspergillus lentulus, part of the Aspergillus fumigatus complex, is an emerging pathogen.
  • It presents a significant health risk due to high drug resistance and mortality rates.

Purpose of the Study:

  • To characterize the intraspecies morphology of Aspergillus lentulus.
  • To assess the virulence of Aspergillus lentulus.
  • To determine the in vitro antifungal susceptibility of Aspergillus lentulus.

Main Methods:

  • Cultured Aspergillus lentulus, Aspergillus fumigatus, and Aspergillus fumigatiaffinis isolates.
  • Assessed virulence using a Galleria mellonella infection model.
  • Determined antifungal susceptibility via colorimetric microdilution with Sensititre YeastOne® panels.

Main Results:

  • Aspergillus lentulus displayed distinct morphology, delayed sporulation, and reduced spore yield compared to other species.
  • Intraspecies variability was observed in growth and sporulation characteristics.
  • Clinical Aspergillus lentulus isolates showed higher virulence than environmental isolates in the Galleria mellonella model.
  • Antifungal susceptibility testing revealed favorable susceptibility to posaconazole but reduced susceptibility to voriconazole, amphotericin B, and caspofungin, with some isolates showing elevated voriconazole MICs.

Conclusions:

  • Aspergillus lentulus exhibits significant inter- and intrastrain variations in morphology and sporulation.
  • Clinical isolates of Aspergillus lentulus possess greater virulence potential.
  • Posaconazole demonstrates favorable activity against Aspergillus lentulus, while voriconazole, amphotericin B, and caspofungin show reduced susceptibility.